KU Antibiogram

Antibiotic Susceptibility Profile Jan-Dec
2012
# isolates tested
Ampicillin
Ampicillin-sulbactam
Amikacin
Aztreonam
Ceftazidime
Cefepime
Ceftriaxone-CSF a
Ceftriaxone a
Cefazolin
Clindamycin
Inducible Clindamycin R b
Daptomycin
Cost Codes e $ $ $ $$$ $$ $$$ $$ $$ $ $$ $$ $ $ $ $ $$ $ $ $$$ $$$$ $ $ $ $ $
Gram Positive Cocci
Percentage of Susceptible Isolates (MIC breakpoint, g/ml) f
Enterococcus spp. 816 95 98 74 d 96 75 99 9 25 100
Enterococcus faecalis 122 91 Total VRE for all Enterococcus species is 23%
100 53 d 97 19 99 0 19 70
Enterococcus faecium 364 8 94 92 d 10 0 96 98 13 28
Methicillin Susceptible S. aureus 732 44% of all SA isolates were methicillin
73 81 62 97 100 98 86 100 100 100 95 98 100
Methicillin-Resistant S. aureus 571
resistant
50 91 8 97 0 93 24 100 100 98 94 97 100
Staphylococcus epidermidis 217 96 39 81 21 42 100 100 98 83 55 100
Staphylococcus coag. neg. 436 90 39 87 37 100 44 100 100 98 80 58 100
Streptococcus agalactiae 61 100 61 52 92
Streptococcus pneumoniae 200 92 97 85 62 96 98
Gram Negative Bacilli
Percentage of Susceptible Isolates (MIC breakpoint, g/ml) f
Acinetobacter baumanii- First isolate 65 82 69 88 44 61 50 88 65
Acinetobacter baumanii- All isolates 138 55 59 76 39 51 42 79 54
Citrobacter freundii 95 63 100 100 72 100 95 100 85 77 99 76
Citrobacter koseri (diversus) 56 83 100 100 100 97 100 100 100 72 98 94 100 98
Enterobacter aerogenes 128 37 100 100 81 0 100 99 100 8 98 74 100 96
Enterobacter cloacae 332 31 100 97 86 0 98 99 98 21 93 78 97 88
Escherichia coli 2479 50 62 99 97 92 91 100 90 100 85 73 95 100 74
Hemophilus influenzae 130 Beta Lactamase Positive 22%
Klebsiella oxytoca 109 83 100 99 100 84 100 100 100 60 97 91 100 96
Klebsiella pneumoniae 695 86 98 97 96 96 100 98 100 96 94 87 100 91
Morganella morgani 77 2 5 100 99 95 1 100 82 100 0 72 91 2 60
Proteus mirabilis 385 75 87 75 99 98 92 100 91 99 77 92 1 74
Pseudomonas aeruginosa-First Isolate 1427 85 62 86 86 79 86 70 87 92
Pseudomonas aeruginosa-All isolates 1633 96 56 81 83 84 82 67 81 95
Pseudomonas aeruginosa-CF patients* 371 35 61 76 67 39 64 40 75 73
Serratia marcescens 83 3 54 100 100 100 100 100 97 93 96 99
11917
* tested with disk diffusion method
As of Jan 2002 the Clinical Laboratory Standards Institute (CLSI) has two breakpoints for S. pneumoniaeCSF isolates are considered susceptible at < 0.5 ug/mL and all other isolates are considered susceptible at

Antifungal Susceptibility Profile Jan-
Dec 2012
# isolates tested
Cost Codes e PO:$$
$$
$ $ $ $$$$
IV:$$$
Yeast
% Susceptible
Candida albicans 88 97 93 91 97 100 99
5-Flucytocine
Fluconazole
Itraconazole
Voriconazole
Amphotericin B
Caspofungin
K
Candida parapsilosis 26 100 96 96 100 100 100
Candida glabrata 73 100 64 3 84 100 97
Candida tropicalis** 17 88 94 41 94 100 100
* Interpretations are not available for all antifungal
agents. MIC 90 values indicate that 90% of yeast
isolates have an MIC lower than the value
presented. These values are in grey.
**This yeast species has fewer isolates and thus the % susceptible data does not have a high sensitivity.
Urine Bacterial Isolates
Jan-Dec 2012
# isolates tes
Ampicillin
Ampicillin-sulbactam
Amikacin
Cefepime
Ceftriaxone
Cefazolin
Clindamycin
Erythromycin
Gentamicin
Meropenem
Levofloxacin
Piperacillin-tazobactam
Tigecycline
Trimeth/Sulfa
Vancomycin
$ $ $$ $ $$ $ $ $$ $ $ $
Cost Codes h
Percentage of Susceptible Isolates (MIC breakpoint, g/ml) f
SHADING represents "not tested"
Gram Positive Cocci
Enterococcus spp. 522 87 73 73 100 96
Enterococcus faecium 185 8 67 3 100 27
S. aureus 131 57% MRSA
54 44 98 58 93 100
Staphylococcus coag. neg. 428 33% MR staph
50 50 100 43 100 59 100
Gram Negative Bacilli
Citrobacter freundii 57 2 52 42 53 53 40 53 81 36 53
Enterobacter aerogenes 51 42 38 45 45 38 45 71 34 45
Escherichia coli 2111 54 66 97 96 92 91 100 97 100 74
Klebsiella pneumoniae 449 0 87 100 97 97 96 98 100 97 94 100 92
Pseudomonas aeruginosa 288 33 50 97 91 89 88 69 91
Proteus mirabilis 227 78 86 100 99 99 92 92 99 82 89 1 79